received

TAP Sleep Care Secures Full Medicare Portfolio Coverage: Nylon flexTAP Receives PDAC Approval under E0486

December 01, 2025 12:10 ET  | Source: Airway Management, Inc. DALLAS, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Airway Management, the…

1 month ago

Fusemachines Files Q3 2025 Quarterly Report and Discloses Nasdaq Notice

November 28, 2025 16:05 ET  | Source: Fusemachines NEW YORK, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Fusemachines Inc. (“Fusemachines” or…

1 month ago

Euro NCAPs SAFER TRUCKS Programme wins Prince Michael International Road Safety Award 2025

Leuven, Belgium – Euro NCAP is proud to announce that its groundbreaking SAFER TRUCKS programme has received the 2025 Prince…

1 month ago

Lang Ping and Ral de Jess Trujillo Daz honoured with IOC Coaches Lifetime Achievement Award

24 November 2025 - Volleyball coach Lang Ping from China and wrestling coach Raúl de Jesús Trujillo Díaz from Cuba…

2 months ago

Cell Impact has been awarded gold medal by EcoVadis

KARLSKOGA, Sweden, Nov. 11, 2025 /PRNewswire/ -- Last year, Cell Impact was awarded silver by EcoVadis. This year, the company has…

2 months ago

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

November 08, 2025 17:13 ET  | Source: Intellia Therapeutics, Inc. Deep, stable and durable reductions in kallikrein observed Among 32 patients…

2 months ago

Andor Health’s Agentic AI Platform, ThinkAndor, Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health

Recognized for its transformational innovation and customer impact in driving the evolution of acute care virtual health through advanced, agentic…

2 months ago

LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 05, 2025 08:00 ET  | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine ophthalmic solution) 1.44% received FDA approval for the…

2 months ago

Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa

DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive long-term safety results from its EXTEND study, a…

2 months ago

Colt DCS Receives Approval to Expand West London Hyperscale Campus with 2.5 Billion Investment in UK’s AI Economy

Planned three new hyperscale data centres and innovation hub with power secured LONDON, Nov. 4, 2025 /PRNewswire/ -- Colt Data…

2 months ago